Advertisement
Clinical study| Volume 62, P155-161, April 2019

Download started.

Ok

Plasma and CSF miRNA dysregulations in subarachnoid hemorrhage reveal clinical courses and underlying pathways

  • Matthew Tai Hei Chan
    Affiliations
    Division of Neurosurgery, Department of Surgery, Prince of Wales Hospital, 4/F, Department of Surgery, Lui Che Woo Clinical Sciences Building, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, NT, Hong Kong, China
    Search for articles by this author
  • Jennie Yuet Yi Wong
    Affiliations
    Division of Neurosurgery, Department of Surgery, Prince of Wales Hospital, 4/F, Department of Surgery, Lui Che Woo Clinical Sciences Building, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, NT, Hong Kong, China
    Search for articles by this author
  • Anthony Ka Tsun Leung
    Affiliations
    Division of Neurosurgery, Department of Surgery, Prince of Wales Hospital, 4/F, Department of Surgery, Lui Che Woo Clinical Sciences Building, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, NT, Hong Kong, China
    Search for articles by this author
  • Gang Lu
    Affiliations
    Division of Neurosurgery, Department of Surgery, Prince of Wales Hospital, 4/F, Department of Surgery, Lui Che Woo Clinical Sciences Building, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, NT, Hong Kong, China

    CUHK-SDU Joint Laboratory on Reproductive Genetics, School of Biomedical Sciences, 7/F, Lo Kwee-Seong Integrated Biomedical Sciences Building, Area 39, School of Biomedical Sciences, Faculty of Medicine, the Chinese University of Hong Kong, Shatin, Hong Kong, China
    Search for articles by this author
  • Wai Sang Poon
    Affiliations
    Division of Neurosurgery, Department of Surgery, Prince of Wales Hospital, 4/F, Department of Surgery, Lui Che Woo Clinical Sciences Building, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, NT, Hong Kong, China
    Search for articles by this author
  • Alexander Yuk-Lun Lau
    Affiliations
    Division of Neurology, Department of Medicine and Therapeutics, Chinese University of Hong Kong, 9/F Department, Department of Medicine and Therapeutics, Lui Che Woo Clinical Sciences Building, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, NT, Hong Kong, China
    Search for articles by this author
  • Wai Yee Chan
    Correspondence
    Corresponding authors at: Rm G03A, Lo Kwee-Seong Integrated Biomedical Sciences Building, Area 39, School of Biomedical Sciences, Faculty of Medicine, the Chinese University of Hong Kong, Shatin, Hong Kong, China (W.Y. Chan).
    Affiliations
    CUHK-SDU Joint Laboratory on Reproductive Genetics, School of Biomedical Sciences, 7/F, Lo Kwee-Seong Integrated Biomedical Sciences Building, Area 39, School of Biomedical Sciences, Faculty of Medicine, the Chinese University of Hong Kong, Shatin, Hong Kong, China
    Search for articles by this author
  • George Kwok Chu Wong
    Correspondence
    Corresponding authors at: Rm G03A, Lo Kwee-Seong Integrated Biomedical Sciences Building, Area 39, School of Biomedical Sciences, Faculty of Medicine, the Chinese University of Hong Kong, Shatin, Hong Kong, China (W.Y. Chan).
    Affiliations
    Division of Neurosurgery, Department of Surgery, Prince of Wales Hospital, 4/F, Department of Surgery, Lui Che Woo Clinical Sciences Building, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, NT, Hong Kong, China
    Search for articles by this author
Published:November 24, 2018DOI:https://doi.org/10.1016/j.jocn.2018.11.038

      Highlights

      • miRNA differentiate SAH complications such as delayed cerebral infarction.
      • Early Brain Injury restructures miRNA expression in cerebrospinal fluid.
      • miRNA fingerprints reflect blood-brain barrier instability, autophagy and apoptosis.
      • miRNA in SAH and ischemic stroke overlap and highlight shared pathophysiology.

      Abstract

      Background

      Subarachnoid hemorrhage (SAH) is fatal and detrimental to quality of life.
      Clinically, options for monitoring are often limited, potentially missing subtle neurological changes especially in low-grade patients. This article reviewed miRNA dysregulation in SAH and analyzed their functional and clinical relevance.

      Methods

      With adherence to PRISMA guideline, PubMed, EMBASE, GEO and ArrayExpress were searched comprehensively for relevant clinical and animal models. Datasets were analyzed and enriched by experimentally validated targets and multiple databases using R v3.4.2, Ingenuity Pathway Analysis, and miRPath v3.0.

      Results

      Among 1926 search results, 18 studies were screened for full-text assessment. The 8 included studies revealed a marked miRNA dysregulation after SAH. 2 datasets were retrieved. In both serum and CSF, different miRNA profiles were associated with Early Brain Injury, Delayed Cerebral Infarction, vasospasm and prognosis. In CSF, a dramatic restructure of inter-miRNA correlation matrix was observed. Enrichment analysis revealed strong association (1) BBB instability, with adherens, extra-cellular matrix, actin cytoskeleton, integrin, TGF-β, Wnt/β-catenin etc; (2) autophagy, with MTORC1, HIF-1, ULK2, and FoxO etc; (3) apoptosis, with PI3K-Akt, p53, and AMPK. We analyzed common miRNAs across SAH and cerebral ischemia. They were related to neuronal differentiation, oxidation stress, apoptosis, angiogenesis, Alzheimer’s disease, NMDA-induced calcium influx, excitotoxicity and NO production.

      Conclusions

      Clinical progression of SAH is associated with different miRNA fingerprints. They carry neuro-pathological relevance and can be a potential biomarker which compliments SAH management.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Clinical Neuroscience
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Feigin V.L.
        • Lawes C.M.
        • Bennett D.A.
        • et al.
        Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review.
        Lancet Neurol. 2009; 8: 355-369https://doi.org/10.1016/S1474-4422(09)70025-0
        • Wong G.K.C.
        • Lam S.W.
        • Ngai K.
        • et al.
        Cognitive domain deficits in patients with aneurysmal subarachnoid haemorrhage at 1 year.
        J Neurol Neurosurg Psychiatry. 2013; 84: 1054-1058https://doi.org/10.1136/jnnp-2012-304517
        • Al-Khindi T.
        • Macdonald R.L.
        • Schweizer T.A.
        Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage.
        Stroke. 2010; 41: e519-e536https://doi.org/10.1161/STROKEAHA.110.581975
        • Mirzaei H.
        Stroke in women: risk factors and clinical biomarkers.
        J Cell Biochem. 2017; 118: 4191-4202https://doi.org/10.1002/jcb.26130
        • Sehba F.A.
        • Hou J.
        • Pluta R.M.
        • et al.
        The importance of early brain injury after subarachnoid hemorrhage.
        Prog Neurobiol. 2012; 97: 14-37https://doi.org/10.1016/j.pneurobio.2012.02.003
        • Macdonald R.L.
        • Schweizer T.A.
        Spontaneous subarachnoid haemorrhage.
        Lancet. 2017; 389: 655-666https://doi.org/10.1016/S0140-6736(16)30668-7
        • Hong C.M.
        • Tosun C.
        • Kurland D.B.
        • et al.
        Biomarkers as outcome predictors in subarachnoid hemorrhage – a systematic review.
        Biomarkers. 2014; 19: 95-108https://doi.org/10.3109/1354750X.2014.881418
        • Lin S.
        • Gregory R.I.
        MicroRNA biogenesis pathways in cancer.
        Nat Rev Cancer. 2015; 15: 321-333https://doi.org/10.1038/nrc3932
        • Wang F.E.
        • Zhang C.
        • Maminishkis A.
        • et al.
        MicroRNA-204/211 alters epithelial physiology.
        FASEB J. 2010; 24: 1552-1571https://doi.org/10.1096/fj.08-125856
        • Mellios N.
        • Huang H.-S.
        • Grigorenko A.
        • et al.
        A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex.
        Hum Mol Genet. 2008; 17: 3030-3042https://doi.org/10.1093/hmg/ddn201
        • Yu S.
        • Zeng Y.
        • Sun X.
        Neuroprotective effects of p53/microRNA‑22 regulate inflammation and apoptosis in subarachnoid hemorrhage.
        Int J Mol Med. 2018; https://doi.org/10.3892/ijmm.2018.3392
        • Khoshnam S.E.
        • Winlow W.
        • Farbood Y.
        • et al.
        Emerging roles of microRNAs in ischemic stroke: as possible therapeutic agents.
        J Stroke. 2017; 19: 166-187https://doi.org/10.5853/jos.2016.01368
        • Lau P.
        • Bossers K.
        • Janky R.
        • ’s,
        • et al.
        Alteration of the microRNA network during the progression of Alzheimer’s disease: Profiling of microRNAs in Alzheimer’s disease.
        EMBO Mol Med. 2013; 5: 1613-1634https://doi.org/10.1002/emmm.201201974
        • Grasso M.
        • Piscopo P.
        • Confaloni A.
        • et al.
        Circulating miRNAs as biomarkers for neurodegenerative disorders.
        Molecules. 2014; 19: 6891-6910https://doi.org/10.3390/molecules19056891
        • Li P.
        • Zhang Q.
        • Wu X.
        • et al.
        Circulating microRNAs serve as novel biological markers for intracranial aneurysms.
        J Am Heart Assoc. 2014; 3e000972https://doi.org/10.1161/JAHA.114.000972
        • Meeuwsen J.A.L.
        • van T Hof F.N.G.
        • van W.
        • Rheenen
        • et al.
        Circulating microRNAs in patients with intracranial aneurysms.
        PLoS One. 2017; 12e0176558https://doi.org/10.1371/journal.pone.0176558
        • Huang F.
        • Yi J.
        • Zhou T.
        • et al.
        Toward understanding non-coding RNA roles in intracranial aneurysms and subarachnoid hemorrhage.
        Transl Neurosci. 2017; 8: 54-64https://doi.org/10.1515/tnsci-2017-0010
        • Moher D.
        • Liberati A.
        • Tetzlaff J.
        • et al.
        Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
        PLoS Med. 2009; 6e1000097https://doi.org/10.1371/journal.pmed.1000097
      1. Revelle WR, psych: Procedures for Personality and Psychological Research; 2017.

        • Vlachos I.S.
        • Paraskevopoulou M.D.
        • Karagkouni D.
        • et al.
        DIANA-TarBase v7. 0: indexing more than half a million experimentally supported miRNA:mRNA interactions.
        Nucleic Acids Res. 2015; 43: D153-D159https://doi.org/10.1093/nar/gku1215
        • Vlachos I.S.
        • Zagganas K.
        • Paraskevopoulou M.D.
        • et al.
        DIANA-miRPath v3. 0: deciphering microRNA function with experimental support.
        Nucleic Acids Res. 2015; 43: W460-W466https://doi.org/10.1093/nar/gkv403
        • Agarwal V.
        • Bell G.W.
        • Nam J.-W.
        • et al.
        Predicting effective microRNA target sites in mammalian mRNAs.
        eLife. 2015; 4https://doi.org/10.7554/eLife.05005
        • Lu G.
        • Wong M.S.
        • Xiong M.Z.Q.
        • et al.
        Circulating MicroRNAs in delayed cerebral infarction after aneurysmal subarachnoid hemorrhage.
        J Am Heart Assoc. 2017; 6https://doi.org/10.1161/JAHA.116.005363
        • Bache S.
        • Rasmussen R.
        • Rossing M.
        • et al.
        MicroRNA changes in cerebrospinal fluid after subarachnoid hemorrhage.
        Stroke. 2017; https://doi.org/10.1161/STROKEAHA.117.017804
        • Wang Z.
        • Shi X.-Y.
        • Yin J.
        • et al.
        Role of autophagy in early brain injury after experimental subarachnoid hemorrhage.
        J Mol Neurosci. 2012; 46: 192-202https://doi.org/10.1007/s12031-011-9575-6
        • Yan H.
        • Chen Y.
        • Li L.
        • et al.
        Decorin alleviated chronic hydrocephalus via inhibiting TGF-β1/Smad/CTGF pathway after subarachnoid hemorrhage in rats.
        Brain Res. 2016; 1630: 241-253https://doi.org/10.1016/j.brainres.2015.11.004
        • Siegel P.M.
        • Massagué J.
        Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer.
        Nat Rev Cancer. 2003; 3: 807-820https://doi.org/10.1038/nrc1208
        • Redshaw N.
        • Camps C.
        • Sharma V.
        • et al.
        TGF-β/Smad2/3 signaling directly regulates several miRNAs in mouse ES cells and early embryos.
        PLoS One. 2013; 8e55186https://doi.org/10.1371/journal.pone.0055186
        • Tanriverdi T.
        • Sanus G.Z.
        • Ulu M.O.
        • et al.
        Serum and cerebrospinal fluid concentrations of E-selectin in patients with aneurysmal subarachnoid hemorrhage.
        Braz J Med Biol Res. 2005; 38 (S0100-879X2005001100020): 1703-1710
        • Giancotti F.G.
        Integrin signaling.
        Science. 1999; 285: 1028-1033https://doi.org/10.1126/science.285.5430.1028
        • Zhang L.
        • Yang X.
        • Yang S.
        • et al.
        The Wnt /β-catenin signaling pathway in the adult neurogenesis: the Wnt /β-catenin signaling pathway.
        Eur J Neurosci. 2011; 33: 1-8https://doi.org/10.1111/j.1460-9568.2010.7483.x
        • Zhang L.
        • Yan R.
        • Zhang Q.
        • et al.
        Survivin, a key component of the Wnt/β-catenin signaling pathway, contributes to traumatic brain injury-induced adult neurogenesis in the mouse dentate gyrus.
        Int J Mol Med. 2013; 32: 867-875https://doi.org/10.3892/ijmm.2013.1456
        • Hasegawa Y.
        • Suzuki H.
        • Sozen T.
        Apoptotic Mechanisms for Neuronal Cells in Early Brain Injury After Subarachnoid Hemorrhage.
        in: Feng H. Mao Y. Zhang J.H. Early Brain Injury or Cerebral Vasospasm. Springer Vienna, Vienna2011: 43-48https://doi.org/10.1007/978-3-7091-0353-1_8
        • Maiese K.
        FoxO proteins in the nervous system.
        Anal Cell Pathol. 2015; 2015: 1-15https://doi.org/10.1155/2015/569392
        • Harraz M.M.
        • Eacker S.M.
        • Wang X.
        • et al.
        MicroRNA-223 is neuroprotective by targeting glutamate receptors.
        Proc Natl Acad Sci. 2012; 109: 18962-18967https://doi.org/10.1073/pnas.1121288109
        • Zeng L.
        • He X.
        • Wang Y.
        • et al.
        MicroRNA-210 overexpression induces angiogenesis and neurogenesis in the normal adult mouse brain.
        Gene Ther. 2014; 21: 37-43https://doi.org/10.1038/gt.2013.55
        • Stylli S.S.
        • Adamides A.A.
        • Koldej R.M.
        • et al.
        miRNA expression profiling of cerebrospinal fluid in patients with aneurysmal subarachnoid hemorrhage.
        J Neurosurg. 2017; 126: 1131-1139https://doi.org/10.3171/2016.1.JNS151454
        • Powers C.J.
        • Dickerson R.
        • Zhang S.W.
        • et al.
        Human cerebrospinal fluid microRNA: temporal changes following subarachnoid hemorrhage.
        Physiol Genomics. 2016; 48: 361-366https://doi.org/10.1152/physiolgenomics.00052.2015
        • Müller A.
        • Povlsen G.
        • Bang-Berthelsen C.
        • et al.
        Regulation of microRNAs miR-30a and miR-143 in cerebral vasculature after experimental subarachnoid hemorrhage in rats.
        BMC Genomics. 2015; 16: 119https://doi.org/10.1186/s12864-015-1341-7
        • Yang S.
        • Tang W.
        • He Y.
        • et al.
        Long non-coding RNA and microRNA-675/let-7a mediates the protective effect of melatonin against early brain injury after subarachnoid hemorrhage via targeting TP53 and neural growth factor.
        Cell Death Dis. 2018; 9https://doi.org/10.1038/s41419-017-0155-8